← feed

Is NCT03480321 results overdue?

Yes — results are overdue. Primary completion was 2018-04-28; the FDAAA-801 reporting deadline (2019-04-28) passed 2657 days ago and no results are posted on ClinicalTrials.gov.

Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

NCT IDNCT03480321 ↗
SponsorGenovate Biotechnology Co., Ltd., (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-04-28 (ACTUAL)
Reporting deadline2019-04-28 (completion + 365d)
Days overdue2657
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 a94918845788a2c5… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03480321. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →